Skip to main content
. 2023 Apr 30;35(2):163–175. doi: 10.21147/j.issn.1000-9604.2023.02.06

Table 1. Clinical and pathological characteristics of included patients.

Variables n (%)
BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; LMLND, lower mediastinal lymph node dissection; TH, transhiatal. *, Because of the technical errors of the surgical videos, three patients didnot have the data of the dissection time of the LMLND, and one patient didnot have the data of pleural injuries under TH approach. #, Patients combined with trans-thoracic surgeries were excluded.
Sex
 Male 33 (94.3)
 Female 2 (5.7)
Age (year) (Inline graphic) 64.7±5.9
BMI (kg/m2) (Inline graphic) 23.7±2.6
ECOG score
 0 29 (82.9)
 1 5 (14.3)
 3 1 (2.9)
Preoperative treatment 19 (54.3)
(y)cT
 (y)cT2 4 (11.4)
 (y)cT3 21 (60.0)
 (y)cT4a 10 (28.6)
(y)cN
 (y)cN0 4 (11.4)
 (y)cN1 12 (34.3)
 (y)cN2 19 (54.3)
Surgical approach
 Laparoscopic-assisted 31 (88.6)
 Total laparoscopic 4 (11.4)
Extension of gastrectomy
 Total gastrectomy 27 (77.1)
 Proximal gastrectomy 8 (22.9)
Extension of lymph node dissection
 D1+ 2 (5.7)
 D2 33 (94.3)
Extension of LMLND
 Stations 110 and 111 7 (20.0)
 Stations 110, 111, and part of 112 28 (80.0)
Combined organ resection 2 (5.7)
Combined trans-thoracic surgery 3 (8.6)
Transfer to open surgery 1 (2.9)
Pleural injury under TH approach*
 No injuries 21 (61.8)
 Injuries to both sides 2 (5.9)
 Injuries to left side 9 (26.5)
 Injuries to right side 2 (5.9)
Operation time (min) (Inline graphic)# 309.8±69.5
Dissection time of LMLND (min) (Inline graphic)* 18.2±6.3
Incision length (cm) (Inline graphic)# 9.5±4.0
Intra-operative blood loss (mL) (Inline graphic)# 100±70.4
Intra-operative blood transfusion 0 (0)
Siewert type
 Type I 1 (2.9)
 Type II 26 (74.3)
 Type III 8 (22.9)
Esophageal resection (cm)# 2.5±1.0
Tumor length (cm) 4.7±2.8
Proximal margin (cm)# 1.7±0.7
Esophageal invasion (cm) 1.1±1.0
Bormann type
 Type 1 2 (5.7)
 Type 2 7 (20.0)
 Type 3 24 (68.6)
 Type 4 2 (5.7)
No. of LMLND (Inline graphic) 2.0±2.8
Lower mediastinal metastasis 4 (11.4)